Jakavi (ruxolintib)

pCPA File Number: 20754

Negotiation Status:

Concluded with an LOI

Indication(s):

Myelofibrosis

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

PC0012-000

pCPA Engagement Letter Issued:

2013-02-01

Negotiation Process Concluded:

2013-09-03